Fasting and Eating for Health (32 page)

5. Stamler J. Lifestyles, major risk factors, proof and public policy.
Circulation
1978;58:3.

6. Lovastatin for hypercholesterolemia.
The Medical Letter
1987;29:99-101.

7. Frick HM, Elo 0, Haapa K,
et al.
Helsinki Heart Trial study: Primary-prevention trial with gernfibrozil in middle aged men with dyslip idemia.

New England Journal of Medicine
1987;317:1237-1245.

8. Luchi RJ, Scott SM, Deupree RH,
et al.
Comparison of medical and surgical treatment for unstable angina pectoris.
New England Journal of Medicine
1987; 316:977-984.

9. Winslow CM, Kosecoff JB, Chassin M,
et al.
The appropriateness of performing coronary artery bypass surgery.
Journal of the American
Medical Association
1988;260:505-509.

10.
Assessing the Efficacy and Safety ofMedical Technologies.
Washington DC, Congress of the United States, Office of Technology Assessment Publication 163

No. 052-003-00593-0. Government Printing Office, Washington DC, 1978.

11. Hannan EL, Bernard HR, Kilburn HC, O'Donnell JF. Gender differences in mortality rates for coronary artery bypass surgery.
American Heart Journal
1992;123:866-872.

12. Editorial: Brain damage and open-heart surgery.
Lancet
Aug. 12, 1989; 364-366.

13. Taylor K. Brian damage during open-heart surgery.
Thorax
1982;37: 873.

14. Orr W. Sleep disturbances after open heart surgery.
American Journal of
Cardiology
1977;39:196.

15. Henriksen L. Evidence suggestive of diffuse brain damage following cardiac operations.
Lancet
1984;1:816.

16. Cashin LW, Sanmarco ME, Nessim AS, Blankenhorn DH. Accelerated progression of atherosclerosis in coronary vessels with minimal lesions that are bypassed.
New England Journal of Medicine
I984;311(13):824-828.

17. Meier B, King SB, Gruentzig AR,
et al.
Repeat coronary angioplasty.

Journal of the American College of Cardiology
1984;4:463.

18. Ornish D, Brown SE, Scherwitz LW,
et al.
Can lifestyle changes reverse coronary heart disease?
Lancet
1990;336(8708):129-133.

19. Kahn JK. Reversing coronary atherosclerosis.
Postgraduate Medicine
1993;94(1):50-65.

20. Carpi J. Low-fat diet can keep arteries young and disease-free.
Medical
Tribune,
November 25, 1993, p. 3.

21. Ellis F. Angina and vegan diet.
American Heart Journal
1977;1:93(6) :803-4.

22. Blankenhorn DH, Nessim SA, Johnson RL,
et al.
Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.
Journal of the American Medical
Association
1987;257:3233.

23. Wenxun F, Parker R, Parpia B,
et al.
Erythrocyte fatty acids, plasma lipids and cardiovascular disease in rural China.
American Journal of Clinical
Nutrition
1990;52:1027-32.

24. Brody J. Huge study of diet indicts fat and meat.
New York Times,
May 8, 1990, "Science Times" section, p. 1.

25. Diet and disease: The China Study.
Health Science,
September/ October 1992, p. 8.

26. West K.
Epidemiology of Diabetes and Its Vascular Lesions.
New York: Elsevier, 1978, p. 353-402.

27. Freis E. Salt, volume and the prevention of hypertension. Circulation 1976;53:589.

28. Himsworth H. Diet in the aetiology of human diabetes.
Proceedings of the
Royal Society of Medicine
1949;42:323.

29. Ramsey LE; Yeo WW, Jackson PR. Dietary reduction of serum cholesterol concentration: Time to think again.
British Medical Journal
1991;303:953-957.

30. O'Brien BC, Reiser R. Human plasma lipid responses to red meat, poultry, fish, and eggs.
American Journal of Clinical Nutrition
1980;33:2573-2580.

31. Flynn MA, Naumann HD, Nolph GB, Krause G, Ellersieck M. Dietary "meats"

and serum lipids.
American Journal of Clinical Nutrition
1982;35:935-942.

32. McDougall JA. Is the cholesterol scare a scam?
Vegetarian Times,
December 1989, pp. 56-69.

164

33. Sacks F. Ingestion of egg raises plasma-low-density lipoproteins in free-living subjects.
Lancet
1984;1:647-649.

34. McMurry M. The absorption of cholesterol and the sterol balance in the Tarahumara Indians of Mexico fed cholesterol-free and high cholesterol diets.
American Journal of Clinical Nutrition
1985;41:1289-1298.

35. Sorbris R, My KO, Nilsson-Ehle P, Petersson BG, Ockerman PA. Vegetarian fasting of obese patients: A clinical and biochemical evaluation.

Scandinavian Journal of Gastroenterology
1982;17:417-24.

36. Vessby B, Boberg M, Karlstrom B, Lithell H, Werner I.
et al.
Improved metabolic control after supplemented fasting in ovenveight type 2 diabetic patients.
Acta Medica Scandinavica
1984;216:67-274.

37. Brozek J, Wells S, Keys A. Medical aspect of semistarvation in Leningrad.

American Review of Soviet Medicine
1946-7;4:70-86.

38. Wanscher 0, Clemmesen J, Nielsen A. Negative correlation between atherosclerosis and carcinoma.
British Journal of Cancer
1951;5:1345-1354.

39. Gresham GA. Is atheroma a reversible lesion?
Atherosclerosis
1976;23:379-391.

40. Armstrong ML. Evidence of regression of atherosclerosis in primates and man.
Postgraduate Medical Journal
1976;52:456-461.

41. Hopf R. Gleubner M, Babej-Dolle R, Kaltenbach M. Wirksamkeit von chelat bei patienten mit koronarer herzkrankheit.
German Journal of Cardiology
1987;79(suppl. 2):73.

42. Diehm C. "Wundermittel Chelat" anspruch and wirklichkeit.
Zeitschrtft der
Deutschen Herzstiftung
1986;10:11-15.

43. Sloth-Nielsen J, Guldager B, Mouritzen C, Lund EB, Egeblad M, Norregaard 0, Jorgensen SJ, Jelnes R. Arteriographic findings in EDTA chelation therapy on peripheral arteriosclerosis.
American Journal of Surgery
1991;162:122-125.

44. Guldager B, Jelnes R, Jorgenson SJ, Nielsen JS, Klerke A, Mogensen K, Larsens KE, Reimer E, Holm J, Ottesen S. EDTA treatment of intermittent claudication—a double blind, placebo-controlled study.
Journal of Internal
Medicine
1992;231:261-267.

45. Duncan GG, Cristofori FC, Yue JK, Murthy MSJ. The control of obesity by intermittent fasts.
Medical Clinics of North America
1964;48:1359-1372.

46. Suzuki J, Yamauchi Y, Horikawa M, Yamagata S. Fasting therapy for psychosomatic diseases with special reference to its indication and therapeutic mechanism.
Tohoku Journal of Experimental Medicine
(suppl) 1976;118:245-259.

47. Krotkiewski M, Ruzyllo E, Kotowska A. Obesity and arterial hypertension: II. Effect of a reducing diet and fasting.
Polish Medical Science and History
1967;10:58-62.

48. Goldhamer A. The effect of water fasting on hypertension (study in progress). Center for Conservative Therapy, Pengrove, Cal. Personal communication, August 30,1994.

49. Bloom WL, Azar G, Smith EG. Changes in heart size and plasma volume during fasting.
Metabolism.
1966;15:409-413.

50. Haxhe JJ. Experimental undernutrition: I. Its effects on cardiac output.

Metabolism
1967;16:1086-91.

51. Rouse IL, Beilin LJ, Armstrong BK, Vandongen R. Blood pressure lowering 165

effects of vegetarian diet: Controlled trial in normotensive subjects.
Lancet
1983;1:5-9.

52. Douglass J, Rasgon IM, Fleiss PM,
et al.
Effects of a raw food diet on hypertension and obesity.
Southern Medical Journal
1985 ; 78( 7) :841.

53. Kannel WB.
Coronary Risk Handbook: Estimating Risk of Coronary Heart
Disease in Daily Practice.
New York: American Heart Association, 1973.

54. Ames RP. Antihypertensive therapy and risk factors for coronary heart disease.
Practical Cardiology
1989;15:49-66.

55. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease.
Jounzal of the American Medical Association
1988;260:2259-2263.

56. Muliar LA, Mishchenko VP, Loban GA, Goncharenko LL, Bobvrev VN. Effect ofcomplete fasting on the coagulative and antioxidative properties of blood.
Voprosy Pitaniya
July-August 1984;4:20-23. (ISSN 0042-8833.

Journal Code: XK4. Language: Russian. Summary language: English.) 57. Miettinen M. Effect of fasting on fibrinolysis and blood coagulation.

American Journal of Cardiology
1962; 10:532-534.

58. Menon IS. Fasting and non-fasting fibrinolytic activity. Laboratory Practice 1967;16:469-470.

59. Lawlor T, Wells DG. Metabolic hazards of fasting. American Journal of Clinical Nutrition 1969;22:1142-1148.

60. Stechschulte D. Dunn M. Starvation and heart failure. Journal of the Kansas Medical Society, November 1965, pp. 500-502.

61. Merrill AJ. Intractable heart failure management with 5-7 days of fasting, a preliminary trial.
American Heart Journal
1964;67:433-436.

62. Bloom WL, Mitchell W. Salt excretion of fasting patients. Archives of Internal Medicine 1960; 106:321-326.

63. Weinsier RL. Fasting: A review with emphasis on the electrolytes.

American Journal of Medicine
1971;50:233-240.

1. Howard BV. Lipoprotein metabolism in diabetes mellitus. Journal of Lipid Research 1987;28:613-628.

2. Insulin therapy may promote atherosclerosis.
Family Practice News,
March 1, 1992, p. 42.

3. Kahn JK. Reversing coronary atherosclerosis.
Postgraduate Medicine
1993;94:50-65.

4. Carre J. Low-fat diet can keep arteries young and disease-free.
Medicine
Tribune,
November 25, 1993, p. 3.

5. Wenxun F, Parker R, Parpia B,
et al.
Erythrocyte fatty acids, plasma lipids and cardiovascular disease in rural China.
American Journal of Clinical
Nutrition
1990;52:1027-32.

6. West K.
Epidemiology ofDiabetes and Its Vascular Lesions.
New York: Elsevier, 1978, pp. 353-402.

7. Sweeney J. Dietary factors that influence the dextrose tolerance test: A preliminary study.
Archives of Internal Medicine
1927;40:818.

8. Hollenbeck C, Donner CC, Williams RA, Reaven GM. The effects of variations in percent of naturally occurring complex and simple carbohydrates on plasma glucose and insulin response in individuals with 166

non-insulin dependent diabetes mellitus.
Diabetes
1985;34:151.

9. To preserve their health and heritage, Arizona Indians reclaim ancient foods.
New York Times,
May 21, 1991, pp. C1,C10.

10. Himsworth H. Diet in the etiology of human diabetes.
Proceedings of the
Royal Society of Medicine
1949;42:323-326.

11. Kawate R. Diabetes mellitus and its vascular complications in Japanese migrants on the island of Hawaii.
Diabetes Care
1979;2:161-170.

12. Insulin therapy may promote atherosclerosis.
Family Practice News.

13. Zoler LZ. Insulin therapy discouraged in type II diabetes patients.
Family
Practice News,
Sept. 15, 1993, pp. 1,26.

14. Berger W. Incidence of severe side effects during therapy with sulfonvlureas and biguanides.
Hormone and Metabolic Research
Supplement
1985;15:111-5:

15. Boyd AE. Sulfonylurea receptors, ion channels, and fruit flies.
Diabetes
1988;37:847-50.

16. Kolterman OG, Gray RS, Shapiro G,
et al.
The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects.
Diabetes
1984;33:346-54.

17. Snowdon DA. Animal product consumption and mortality because of all causes combined, coronary heart disease, stroke, diabetes, and cancer in Seventh-Day Adventists.
American Journal of Clinical Nutrition
1988;48:739-48.

18. Kahn HA, Phillips RL, Snowdon DA, Chop W. Association between reported diet and all-cause mortality.
American Journal of Epidemiology
1984;119

(5) : 775-787.

19. Paolisso GP, D?Amore A, Giugliano D,
et al.
Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin dependent diabetic patients.
American Journal of Clinical Nutrition
1993;57:650-656.

20. Davie S, Gould B, Yudkin J. Effect of vitamin Con glycosylation of proteins.

Diabetes
1992;41:167-173.

21. Allen FM. Prolonged fasting in diabetes.
American Journal of the Medical
Sciences
1915;159(4):480-485.

22. Vessby B, Boberg M, Karlstrom B,
et al.
Improved metabolic control after supplemented fasting in overweight type II diabetic patients
Acta Medica
Scandinavia
1984;216:67-74.

23. McCarty MF. Maturity-onset diabetes-toward a physiologically appropriate management.
Medical Hypothesis
(England) 1981;7(10): 1265-1285.

24. Gueris J, Segrestaa JM, Lamotte M. Insulinemia in the obese before and after fasting therapy.
Journal Annuel Diabetologie Hotel Dieu
(France) 1969;10:287-292.

1. Halla JR, Volanakis JE, Schrohenloher RE. Immune complexes in rheumatoid arthritis sera and svnovial fluids.
Arthritis and Rheumatism
1979;22(5):440-448.